Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Dec;96(6):2683–2692. doi: 10.1172/JCI118335

Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism.

S H Pearce 1, D Trump 1, C Wooding 1, G M Besser 1, S L Chew 1, D B Grant 1, D A Heath 1, I A Hughes 1, C R Paterson 1, M P Whyte 1, et al.
PMCID: PMC185975  PMID: 8675635

Abstract

Familial benign hypercalcemia (FBH) and neonatal hyperparathyroidism (NHPT) are disorders of calcium homeostasis that are associated with missense mutations of the calcium-sensing receptor (CaR). We have undertaken studies to characterize such CaR mutations in FBH and NHPT and to explore methods for their more rapid detection. Nine unrelated kindreds (39 affected, 32 unaffected members) with FBH and three unrelated children with sporadic NHPT were investigated for mutations in the 3,234-bp coding region of the CaR gene by DNA sequencing. Six novel heterozygous (one nonsense and five missense) mutations were identified in six of the nine FBH kindreds, and two de novo heterozygous missense mutations and one homozygous frame-shift mutation were identified in the three children with NHPT. Our results expand the phenotypes associated with CaR mutations to include sporadic NHPT. Single-stranded conformational polymorphism analysis was found to be a sensitive and specific mutational screening method that detected > 85% of these CaR gene mutations. The single-stranded conformational polymorphism identification of CaR mutations may help in the distinction of FBH from mild primary hyperparathyroidism which can be clinically difficult. Thus, the results of our study will help to supplement the clinical evaluation of some hypercalcemic patients and to elucidate further the structure-function relationships of the CaR.

Full text

PDF
2683

Images in this article

2684Image
on p.2684
2684Image
on p.2684
2684Image
on p.2684
2684Image
on p.2684
2684Image
on p.2684
2685Image
on p.2685
2687Image
on p.2687
2688Image
on p.2688
2689Image
on p.2689
2690Image
on p.2690
2690Image
on p.2690
2691Image
on p.2691

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almahroos G. M., Docherty K., Fletcher J. A., Webb T., Heath D. A. Studies of the parathyroid hormone gene in normal subjects, and in subjects with primary hyperparathyroidism and familial benign hypercalcaemia. J Endocrinol. 1987 Oct;115(1):183–186. doi: 10.1677/joe.0.1150183. [DOI] [PubMed] [Google Scholar]
  2. Brown E. M., Gamba G., Riccardi D., Lombardi M., Butters R., Kifor O., Sun A., Hediger M. A., Lytton J., Hebert S. C. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature. 1993 Dec 9;366(6455):575–580. doi: 10.1038/366575a0. [DOI] [PubMed] [Google Scholar]
  3. Chou Y. H., Brown E. M., Levi T., Crowe G., Atkinson A. B., Arnqvist H. J., Toss G., Fuleihan G. E., Seidman J. G., Seidman C. E. The gene responsible for familial hypocalciuric hypercalcemia maps to chromosome 3q in four unrelated families. Nat Genet. 1992 Jul;1(4):295–300. doi: 10.1038/ng0792-295. [DOI] [PubMed] [Google Scholar]
  4. Chou Y. H., Pollak M. R., Brandi M. L., Toss G., Arnqvist H., Atkinson A. B., Papapoulos S. E., Marx S., Brown E. M., Seidman J. G. Mutations in the human Ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia. Am J Hum Genet. 1995 May;56(5):1075–1079. [PMC free article] [PubMed] [Google Scholar]
  5. Dejager S., Mietus-Snyder M., Friera A., Pitas R. E. Dominant negative mutations of the scavenger receptor. Native receptor inactivation by expression of truncated variants. J Clin Invest. 1993 Aug;92(2):894–902. doi: 10.1172/JCI116664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dezateux C. A., Hyde J. C., Hoey H. M., O'Riordan J. L., Spitz L., Taylor G. W., Grant D. B. Neonatal hyperparathyroidism. Eur J Pediatr. 1984 Jun;142(2):135–136. doi: 10.1007/BF00445595. [DOI] [PubMed] [Google Scholar]
  7. Garrett J. E., Capuano I. V., Hammerland L. G., Hung B. C., Brown E. M., Hebert S. C., Nemeth E. F., Fuller F. Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem. 1995 May 26;270(21):12919–12925. doi: 10.1074/jbc.270.21.12919. [DOI] [PubMed] [Google Scholar]
  8. Grompe M. The rapid detection of unknown mutations in nucleic acids. Nat Genet. 1993 Oct;5(2):111–117. doi: 10.1038/ng1093-111. [DOI] [PubMed] [Google Scholar]
  9. Heath H., 3rd Familial benign (hypocalciuric) hypercalcemia. A troublesome mimic of mild primary hyperparathyroidism. Endocrinol Metab Clin North Am. 1989 Sep;18(3):723–740. [PubMed] [Google Scholar]
  10. Heath H., 3rd, Jackson C. E., Otterud B., Leppert M. F. Genetic linkage analysis in familial benign (hypocalciuric) hypercalcemia: evidence for locus heterogeneity. Am J Hum Genet. 1993 Jul;53(1):193–200. [PMC free article] [PubMed] [Google Scholar]
  11. Herskowitz I. Functional inactivation of genes by dominant negative mutations. Nature. 1987 Sep 17;329(6136):219–222. doi: 10.1038/329219a0. [DOI] [PubMed] [Google Scholar]
  12. Janicic N., Pausova Z., Cole D. E., Hendy G. N. Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Am J Hum Genet. 1995 Apr;56(4):880–886. [PMC free article] [PubMed] [Google Scholar]
  13. Law W. M., Jr, Heath H., 3rd Familial benign hypercalcemia (hypocalciuric hypercalcemia). Clinical and pathogenetic studies in 21 families. Ann Intern Med. 1985 Apr;102(4):511–519. doi: 10.7326/0003-4819-102-4-511. [DOI] [PubMed] [Google Scholar]
  14. Mackintosh P., Almarhoos G., Heath D. A. HLA linkage with familial vesicoureteral reflux and familial pelvi-ureteric junction obstruction. Tissue Antigens. 1989 Sep;34(3):185–189. doi: 10.1111/j.1399-0039.1989.tb01735.x. [DOI] [PubMed] [Google Scholar]
  15. Maggio R., Vogel Z., Wess J. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):3103–3107. doi: 10.1073/pnas.90.7.3103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Marx S. J., Attie M. F., Levine M. A., Spiegel A. M., Downs R. W., Jr, Lasker R. D. The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine (Baltimore) 1981 Nov;60(6):397–412. doi: 10.1097/00005792-198111000-00002. [DOI] [PubMed] [Google Scholar]
  17. Marx S. J., Attie M. F., Spiegel A. M., Levine M. A., Lasker R. D., Fox M. An association between neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia in three kindreds. N Engl J Med. 1982 Feb 4;306(5):257–264. doi: 10.1056/NEJM198202043060502. [DOI] [PubMed] [Google Scholar]
  18. Marx S. J., Stock J. L., Attie M. F., Downs R. W., Jr, Gardner D. G., Brown E. M., Spiegel A. M., Doppman J. L., Brennan M. F. Familial hypocalciuric hypercalcemia: recognition among patients referred after unsuccessful parathyroid exploration. Ann Intern Med. 1980 Mar;92(3):351–356. doi: 10.7326/0003-4819-92-3-351. [DOI] [PubMed] [Google Scholar]
  19. McMurtry C. T., Schranck F. W., Walkenhorst D. A., Murphy W. A., Kocher D. B., Teitelbaum S. L., Rupich R. C., Whyte M. P. Significant developmental elevation in serum parathyroid hormone levels in a large kindred with familial benign (hypocalciuric) hypercalcemia. Am J Med. 1992 Sep;93(3):247–258. doi: 10.1016/0002-9343(92)90229-5. [DOI] [PubMed] [Google Scholar]
  20. Meeran K., Husain M., Puccini M., Scott H., Dionisi-Vici C., Harvey D. R., Lynn J., Thakker R. V. Neonatal primary hyperparathyroidism masked by vitamin D deficiency. Clin Endocrinol (Oxf) 1994 Oct;41(4):531–534. doi: 10.1111/j.1365-2265.1994.tb02586.x. [DOI] [PubMed] [Google Scholar]
  21. Nishiyama S., Tomoeda S., Inoue F., Ohta T., Matsuda I. Self-limited neonatal familial hyperparathyroidism associated with hypercalciuria and renal tubular acidosis in three siblings. Pediatrics. 1990 Sep;86(3):421–427. [PubMed] [Google Scholar]
  22. Page L. A., Haddow J. E. Self-limited neonatal hyperparathyroidism in familial hypocalciuric hypercalcemia. J Pediatr. 1987 Aug;111(2):261–264. doi: 10.1016/s0022-3476(87)80083-5. [DOI] [PubMed] [Google Scholar]
  23. Parkinson D. B., Thakker R. V. A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism. Nat Genet. 1992 May;1(2):149–152. doi: 10.1038/ng0592-149. [DOI] [PubMed] [Google Scholar]
  24. Paterson C. R., Gunn A. Familial benign hypercalcaemia. Lancet. 1981 Jul 11;2(8237):61–63. doi: 10.1016/s0140-6736(81)90410-4. [DOI] [PubMed] [Google Scholar]
  25. Pollak M. R., Brown E. M., Chou Y. H., Hebert S. C., Marx S. J., Steinmann B., Levi T., Seidman C. E., Seidman J. G. Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell. 1993 Dec 31;75(7):1297–1303. doi: 10.1016/0092-8674(93)90617-y. [DOI] [PubMed] [Google Scholar]
  26. Pollak M. R., Brown E. M., Estep H. L., McLaine P. N., Kifor O., Park J., Hebert S. C., Seidman C. E., Seidman J. G. Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet. 1994 Nov;8(3):303–307. doi: 10.1038/ng1194-303. [DOI] [PubMed] [Google Scholar]
  27. Pollak M. R., Chou Y. H., Marx S. J., Steinmann B., Cole D. E., Brandi M. L., Papapoulos S. E., Menko F. H., Hendy G. N., Brown E. M. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest. 1994 Mar;93(3):1108–1112. doi: 10.1172/JCI117062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Riccardi D., Park J., Lee W. S., Gamba G., Brown E. M., Hebert S. C. Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc Natl Acad Sci U S A. 1995 Jan 3;92(1):131–135. doi: 10.1073/pnas.92.1.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Scheinman S. J., Pook M. A., Wooding C., Pang J. T., Frymoyer P. A., Thakker R. V. Mapping the gene causing X-linked recessive nephrolithiasis to Xp11.22 by linkage studies. J Clin Invest. 1993 Jun;91(6):2351–2357. doi: 10.1172/JCI116467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sopwith A. M., Burns C., Grant D. B., Taylor G. W., Wolf E., Besser G. M. Familial hypocalciuric hypercalcaemia: association with neonatal primary hyperparathyroidism, and possible linkage with HLA haplotype. Clin Endocrinol (Oxf) 1984 Jul;21(1):57–64. doi: 10.1111/j.1365-2265.1984.tb00136.x. [DOI] [PubMed] [Google Scholar]
  31. Spiegel A. M., Harrison H. E., Marx S. J., Brown E. M., Aurbach G. D. Neonatal primary hyperparathyroidism with autosomal dominant inheritance. J Pediatr. 1977 Feb;90(2):269–272. doi: 10.1016/s0022-3476(77)80649-5. [DOI] [PubMed] [Google Scholar]
  32. Thakker R. V., Davies K. E., Whyte M. P., Wooding C., O'Riordan J. L. Mapping the gene causing X-linked recessive idiopathic hypoparathyroidism to Xq26-Xq27 by linkage studies. J Clin Invest. 1990 Jul;86(1):40–45. doi: 10.1172/JCI114712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Thakker R. V., Pook M. A., Wooding C., Boscaro M., Scanarini M., Clayton R. N. Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. J Clin Invest. 1993 Jun;91(6):2815–2821. doi: 10.1172/JCI116524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Trump D., Whyte M. P., Wooding C., Pang J. T., Pearce S. H., Kocher D. B., Thakker R. V. Linkage studies in a kindred from Oklahoma, with familial benign (hypocalciuric) hypercalcaemia (FBH) and developmental elevations in serum parathyroid hormone levels, indicate a third locus for FBH. Hum Genet. 1995 Aug;96(2):183–187. doi: 10.1007/BF00207376. [DOI] [PubMed] [Google Scholar]
  35. Wilkinson H., James J. Self limiting neonatal primary hyperparathyroidism associated with familial hypocalciuric hypercalcaemia. Arch Dis Child. 1993 Sep;69(3 Spec No):319–321. doi: 10.1136/adc.69.3_spec_no.319. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES